These data suggest that changes in FoxO1 expression and activity may have important effects on macrophage homeostasis, spurring the hypothesis that macrophage FoxO1 dysregulation may link insulin resistance to abnormal macrophage activation and hepatic inflammation in obesity. The gene discussed is FOXO1; the disease is obesity due to melanocortin 4 receptor deficiency.